サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1472605

PCR市場：qPCR、dPCR、シングルプレックス、マルチプレックス市場、用途別、製品別、場所別 - カスタマイズ予測と分析（2024年～2028年）

PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2024 to 2028

出版日
ページ情報
英文 503 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
PCR市場：qPCR、dPCR、シングルプレックス、マルチプレックス市場、用途別、製品別、場所別 - カスタマイズ予測と分析（2024年～2028年）
出版日: 2024年02月01日
発行: Howe Sound Research
ページ情報: 英文 503 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

パンデミックはPCRを支配的な技術的役割に押し上げましたが、今や新しい市場と技術が生まれ、病気の診断方法を変えようとしています。PCRはその中心的役割を担っています。

当レポートは、世界のPCR市場について調査し、市場の概要とともに、用途別、製品別、場所別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

  • PCR技術とは何か
  • PCR検査と症候群検査
  • 市場の定義
  • 調査手法
  • 視点：ヘルスケアとIVD業界

第3章 PCR-PCR技術ガイド

  • コンセプト
  • 用途
  • PCRの利点と欠点
  • PCRのさまざまなタイプ

第4章 業界の概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関

第5章 市場動向

  • 成長促進要因
  • 成長抑制要因
  • 診断技術開発

第6章 PCRの最近の動向

第7章 主要企業のプロファイル

  • Abbott Laboratories
  • Accelerate Diagnostics
  • Ador Diagnostics
  • ADT Biotech
  • Agilent
  • Akonni Biosystems
  • Altona Diagnostics
  • Alveo Technologies
  • Amoy Diagnostics Co., Ltd.
  • Anatolia Geneworks
  • Applied BioCode
  • Applied DNA Sciences
  • Aurora Biomed
  • Aus Diagnostics
  • AVIVA Systems Biology
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid（Danaher）
  • Credo Diagnostics Biomedical
  • CTK Biotech
  • Cue Health
  • Curetis（OpGen）
  • Diagenode Diagnostics（Hologic）
  • Diasorin S.p.A.
  • Eiken Chemical
  • Enzo Biochem
  • Eurofins Scientific
  • Fluxergy
  • Fujirebio
  • Genetic Signatures
  • GenMark Dx（Roche）
  • Greiner Bio-One
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • J&J Innovative Medicine
  • Karius
  • LumiraDx
  • Maxim Biomedical
  • Meridian Bioscience
  • Millipore Sigma
  • Molbio Diagnostics
  • Nanomix
  • NGeneBio
  • Novacyt
  • Nuclein
  • Operon
  • Panagene
  • Precipio
  • Primerdesign（Novacyt）
  • Promega
  • Prominex
  • Qiagen
  • QuantuMDx
  • QuidelOrtho
  • Randox Toxicology
  • R-Biopharm AG
  • Revvity
  • Roche Diagnostics
  • Scope Fluidics
  • SD Biosensor
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • Standard BioTools
  • Stilla Technologies
  • Streamline Scientific
  • T2 Biosystems
  • Thermo Fisher Scientific
  • Uniogen
  • Vela Diagnostics
  • Veramarx
  • Veredus Laboratories
  • Vircell
  • Visby Medical
  • XCR Diagnostics
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第8章 世界のPCR市場

  • 国別：世界市場概要
  • 用途別：世界市場概要
  • 技術別：世界市場概要
  • 製品別：世界市場概要
  • 地域別：世界市場概要

第9章 世界のPCR市場：用途別

  • 臨床マルチプレックス
  • 臨床シングルプレックス
  • PCR研究
  • その他

第10章 世界のPCR市場：技術別

  • 定量PCR
  • dPCR
  • その他

第11章 世界のPCR市場：製品別

  • 機器
  • 核酸抽出
  • 消耗品
  • サービス

第12章 世界のPCR市場：場所別

  • 臨床検査室
  • ポイントオブケア
  • 商業
  • 製薬
  • その他

第13章 付録

図表

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Three Factors Limiting Growth
  • Table 4: Market Size by Country
  • Table 5: Global Market by Application
  • Table 6: Global Market by Technology
  • Table 7: Global Market by Product
  • Table 8: Global Market by Place
  • Table 9: PCR Clinical Multiplex by Country
  • Table 10: PCR Clinical Singleplex by Country
  • Table 11: PCR Research by Country
  • Table 12: PCR Other Application by Country
  • Table 13: qPCR by Country
  • Table 14: Other Technology by Country
  • Table 15: PCR Instruments by Country
  • Table 16: PCR Nucleic Acid Extraction by Country
  • Table 17: PCR Consumables by Country
  • Table 18: PCR Services by Country
  • Table 19: PCR Clinical Clinical Laboratory by Country
  • Table 20: PCR Point of Care by Country
  • Table 21: PCR Commercial by Country
  • Table 22: PCR Pharmaceutical by Country
  • Table 23: PCR Other Place by Country
  • Table 24: The Most Common Assays
  • Table 25: Largest Revenue Assays
  • Table 26: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: The Global Healthcare Market
  • Figure 2: the Lab Test Pie
  • Figure 3: The PCR Process
  • Figure 4: Creation of Sample Droplets for Digital PCR
  • Figure 5: The Road to Diagnostics
  • Figure 6: Comparing Syndromic and Targeted Testing
  • Figure 7: Comparing The New Diagnostics and Traditional Testing
  • Figure 8: Growth rates of PCR Diagnostic Segments
  • Figure 9: Base year Global Market Share Chart
  • Figure 10: PCR Market by Application-Segments Growth
  • Figure 11: PCR Market by Application-Base vs. final
  • Figure 12: PCR Market Base year
  • Figure 13: PCR Market Final Year
  • Figure 14: Application Share by Year
  • Figure 15: PCR Market by Technology-Segments Growth
  • Figure 16: PCR Market by Technology-Base vs. final
  • Figure 17: PCR Market by Technology Base year
  • Figure 18: PCR Market by Technology Final Year
  • Figure 19: Technology Share by Year
  • Figure 20: PCR Market by Product-Segments Growth
  • Figure 21: PCR Market by Product-Base vs. final
  • Figure 22: PCR Market by Product Base year
  • Figure 23: PCR Market by Product Final Year
  • Figure 24: Product Share by Year
  • Figure 25: PCR Market by Place-Segments Growth
  • Figure 26: PCR Market by Place-Base vs. final
  • Figure 27: PCR Market by Place Base year
  • Figure 28: PCR Market by Place Final Year
  • Figure 29: Place Share by Year
  • Figure 30: PCR Clinical Multiplex Testing Growth
  • Figure 31: PCR Clinical Singleplex Testing Growth
  • Figure 32: PCR Research Growth
  • Figure 33: PCR Other Application Growth
  • Figure 34: qPCR Growth
  • Figure 35: dPCR Growth
  • Figure 36: Other Technology Growth
  • Figure 37: PCR Instruments Growth
  • Figure 38: PCR Nucleic Acid Extraction Growth
  • Figure 39: PCR Consumables Growth
  • Figure 40: PCR Services Growth
  • Figure 41: PCR Clinical Clinical Laboratory Growth
  • Figure 42: PCR Point of Care Growth
  • Figure 43: PCR Commercial Growth
  • Figure 44: PCR Pharmaceutical Growth
  • Figure 45: PCR Other Place Growth
  • Figure 46: IVD Test Menu Growth
  • Figure 47: IVD Test Average Fees-A Ten Year View
目次

OVERVIEW:

The pandemic drove PCR into a dominant technology role but now new markets and technologies are opening up that will change how diseases are diagnosed. PCR plays a central role. Find out about the opportunities and threats in this new global market.

The report forecasts the market size out five years with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance The two key trends of Point of Care Testing and Molecular Diagnostics are merging but what does that look like? Find out in this comprehensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What are PCR Technologies?
  • 2.2. PCR and Syndromic Testing
  • 2.3. Market Definition
    • 2.3.1. Market Size
    • 2.3.2. Currency
    • 2.3.3. Years
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare and the IVD Industry
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Diagnostics
    • 2.5.3. Important Role of Insurance for Diagnostics

3. PCR-Guide to PCR Technologies

  • 3.1. Concepts
    • 3.1.1. Method
  • 3.2. Applications
    • 3.2.1. Finding Specific DNA
    • 3.2.2. Measuring DNA
    • 3.2.3. Medical and Diagnostic Applications
      • 3.2.3.1. Carrier, prenatal and tissue typing
      • 3.2.3.2. Cancer Diagnosis and Management
      • 3.2.3.3. Infectious Disease-New Levels of Accuracy and Sensitivity
      • 3.2.3.4. Forensic Applications
      • 3.2.3.5. Science and Research
  • 3.3. PCR-Advantages and Disadvantages
  • 3.4. Different Types of PCR
    • 3.4.1. Simple Changes
      • 3.4.1.1. Multiplex-PCR
      • 3.4.1.2. VNTR PCR
      • 3.4.1.3. Asymmetric PCR
      • 3.4.1.4. Long PCR
      • 3.4.1.5. Nested PCR
      • 3.4.1.6. Quantitative PCR
      • 3.4.1.7. Hot-start PCR
      • 3.4.1.8. Touchdown PCR
      • 3.4.1.9. Assembly PCR
      • 3.4.1.10. Colony PCR
      • 3.4.1.11. Suicide PCR
      • 3.4.1.12. Cold PCR
    • 3.4.2. Digital PCR
      • 3.4.2.1. Droplet Digital PCR
      • 3.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3. Digital PCR in Use
      • 3.4.2.4. Digital PCR Commercial History
    • 3.4.3. Isothermal PCR

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Instrumentation Supplier
    • 4.1.4. Chemical/Reagent Supplier
    • 4.1.5. Pathology Supplier
    • 4.1.6. Independent Clinical Laboratory
    • 4.1.7. Public National/regional Laboratory
    • 4.1.8. Hospital Laboratory
    • 4.1.9. Physicians Office Lab (POLS)
    • 4.1.10. Audit Body
    • 4.1.11. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. A New Standard
    • 5.1.2. Down the Curve We Go
    • 5.1.3. Multiplexing
    • 5.1.4. Syndromic Diagnostics Looks Unstoppable
    • 5.1.5. The Genetic Blizzard
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve
    • 5.2.2. The Other Guys
    • 5.2.3. Systemic Roadblocks
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Instrumentation Curve
    • 5.3.2. Shifting Role of Diagnostics
    • 5.3.3. Diagnostics Moves Out of the Hospital
    • 5.3.4. Disruption Looms
    • 5.3.5. The Next Five Years

6. PCR Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Seegene, Microsoft Collaborate for MDx Development
  • 6.3. QuidelOrtho Expanding Savanna Test Menu
  • 6.4. Binx Health Refocuses on POC STI Testing
  • 6.5. Qiagen, Myriad Genetics Partner to Develop Cancer Dx
  • 6.6. VedaBio Detecting Nucleic Acid With CRISPR
  • 6.7. Evvy Launches Add-on STI Screen
  • 6.8. ChromaCode Shifts to Oncology with dPCR Lung Cancer Test
  • 6.9. Multiplex Meningitis/Encephalitis Panel Market Expanding
  • 6.10. Sensible Dx to Launch 10-Minute POC PCR System
  • 6.11. ReadyGo Dx Plans to Make MDx Testing Easy
  • 6.12. Transformative Biotech Acquires Summit Biolabs' PCR Tech
  • 6.13. Visby Medical POC STI Multiplex Test Cleared
  • 6.14. Sherlock Biosciences Buys Sense Biodetection
  • 6.15. Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
  • 6.16. HealthTrackRx Investing in Rapid Turnaround Times
  • 6.17. LEX Dx Developing Ultra-Fast Low-Cost PCR
  • 6.18. Next-Gen Dx Technologies Face Uncertain Future
  • 6.19. Rover Dx Developing All-Optical Rapid POC qPCR Platform
  • 6.20. ProtonDx Plans Rapid Molecular Dx Instrument
  • 6.21. Innova Medical Group Licenses MDx Tech
  • 6.22. MicroGEM to Grow Market for 30-Minute RT-PCR System
  • 6.23. Precipio Receives CE-IVD Mark for Cancer Panels
  • 6.24. Siemens Healthineers to Develop Next-Gen MDx Platform
  • 6.25. New York State Approves Enzo Biochem HPV Molecular Test
  • 6.26. Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections
  • 6.27. Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System
  • 6.28. Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
  • 6.29. Finnish Firms to Form Point-of-Care Testing Firm
  • 6.30. Visby Medical Scales Up Handheld PCR Test for STIs
  • 6.31. DnaNudge Raises $60M
  • 6.32. Roche Reports Diagnostics Revenue Up 51 Percent
  • 6.33. BforCure Preparing Multiple ID Panels for PoC qPCR Platform
  • 6.34. Enzo Biochem, CLX Health Partner for C19 Testing for Travel
  • 6.35. Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.36. Roche Acquires GenMark
  • 6.37. Handheld qPCR Devices Close to Commercialization
  • 6.38. Nuclein Closes $14M in Funding
  • 6.39. WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.40. Visby Medical to develop rapid Flu-COVID PCR test
  • 6.41. Thermo Fisher to acquire Mesa Biotech

7. Profiles of Key PCR Companies

  • 7.1. Abbott Laboratories
  • 7.2. Accelerate Diagnostics
  • 7.3. Ador Diagnostics
  • 7.4. ADT Biotech
  • 7.5. Agilent
  • 7.6. Akonni Biosystems
  • 7.7. Altona Diagnostics
  • 7.8. Alveo Technologies
  • 7.9. Amoy Diagnostics Co., Ltd.
  • 7.10. Anatolia Geneworks
  • 7.11. Applied BioCode
  • 7.12. Applied DNA Sciences
  • 7.13. Aurora Biomed
  • 7.14. Aus Diagnostics
  • 7.15. AVIVA Systems Biology
  • 7.16. Beckman Coulter Diagnostics (Danaher)
  • 7.17. Becton, Dickinson and Company
  • 7.18. Binx Health
  • 7.19. Biocartis
  • 7.20. bioMerieux Diagnostics
  • 7.21. Bioneer Corporation
  • 7.22. Bio-Rad Laboratories, Inc
  • 7.23. Bosch Healthcare Solutions GmbH
  • 7.24. Bruker
  • 7.25. Caris Molecular Diagnostics
  • 7.26. Cepheid (Danaher)
  • 7.27. Credo Diagnostics Biomedical
  • 7.28. CTK Biotech
  • 7.29. Cue Health
  • 7.30. Curetis (OpGen)
  • 7.31. Diagenode Diagnostics (Hologic)
  • 7.32. Diasorin S.p.A.
  • 7.33. Eiken Chemical
  • 7.34. Enzo Biochem
  • 7.35. Eurofins Scientific
  • 7.36. Fluxergy
  • 7.37. Fujirebio
  • 7.38. Genetic Signatures
  • 7.39. GenMark Dx (Roche)
  • 7.40. Greiner Bio-One
  • 7.41. Hologic
  • 7.42. Immunexpress
  • 7.43. Inflammatix
  • 7.44. Invetech
  • 7.45. J&J Innovative Medicine
  • 7.46. Karius
  • 7.47. LumiraDx
  • 7.48. Maxim Biomedical
  • 7.49. Meridian Bioscience
  • 7.50. Millipore Sigma
  • 7.51. Molbio Diagnostics
  • 7.52. Nanomix
  • 7.53. NGeneBio
  • 7.54. Novacyt
  • 7.55. Nuclein
  • 7.56. Operon
  • 7.57. Panagene
  • 7.58. Precipio
  • 7.59. Primerdesign (Novacyt)
  • 7.60. Promega
  • 7.61. Prominex
  • 7.62. Qiagen
  • 7.63. QuantuMDx
  • 7.64. QuidelOrtho
  • 7.65. Randox Toxicology
  • 7.66. R-Biopharm AG
  • 7.67. Revvity
  • 7.68. Roche Diagnostics
  • 7.69. Scope Fluidics
  • 7.70. SD Biosensor
  • 7.71. Seegene
  • 7.72. Siemens Healthineers
  • 7.73. SkylineDx
  • 7.74. Sona Nanotech
  • 7.75. SpeeDx
  • 7.76. Standard BioTools
  • 7.77. Stilla Technologies
  • 7.78. Streamline Scientific
  • 7.79. T2 Biosystems
  • 7.80. Thermo Fisher Scientific
  • 7.81. Uniogen
  • 7.82. Vela Diagnostics
  • 7.83. Veramarx
  • 7.84. Veredus Laboratories
  • 7.85. Vircell
  • 7.86. Visby Medical
  • 7.87. XCR Diagnostics
  • 7.88. YD Diagnostics
  • 7.89. Zhejiang Orient Gene Biotech

8. The Global PCR Markets

  • 8.1. PCR-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart-Global Market by Country
  • 8.2. Global Market by Application-Overview
    • 8.2.1. Table-Global Market by Application
    • 8.2.2. Chart-Global Market by Application-Segments Growth
    • 8.2.3. Chart-Global Market by Application-Base/Final Comparison
    • 8.2.4. Chart-Global Market by Application-Base Year
    • 8.2.5. Chart-Global Market by Application-Final Year
    • 8.2.6. Chart-Global Market by Application-Share by Year
  • 8.3. Global Market by Technology-Overview
    • 8.3.1. Table-Global Market by Technology
    • 8.3.2. Chart-Global Market by Technology-Segments Growth
    • 8.3.3. Chart-Global Market by Technology-Base/Final Comparison
    • 8.3.4. Chart-Global Market by Technology-Base Year
    • 8.3.5. Chart-Global Market by Technology-Final Year
    • 8.3.6. Chart-Global Market by Technology-Share by Year
  • 8.4. Global Market by Product-Overview
    • 8.4.1. Table-Global Market by Product
    • 8.4.2. Chart-Global Market by Product-Segments Growth
    • 8.4.3. Chart-Global Market by Product-Base/Final Comparison
    • 8.4.4. Chart-Global Market by Product-Base Year
    • 8.4.5. Chart-Global Market by Product-Final Year
    • 8.4.6. Chart-Global Market by Product-Share by Year
  • 8.5. Global Market by Place-Overview
    • 8.5.1. Table-Global Market by Place
    • 8.5.2. Chart-Global Market by Place-Segments Growth
    • 8.5.3. Chart-Global Market by Place-Base/Final Comparison
    • 8.5.4. Chart-Global Market by Place-Base Year
    • 8.5.5. Chart-Global Market by Place-Final Year
    • 8.5.6. Chart-Global Market by Place-Share by Year

9. Global PCR Markets-By Application

  • 9.1. PCR Clinical Multiplex
    • 9.1.1. Table PCR Clinical Multiplex Testing-by Country
    • 9.1.2. Chart-PCR Clinical Multiplex Testing Growth
  • 9.2. PCR Clinical Singleplex
    • 9.2.1. Table PCR Clinical Singleplex Testing-by Country
    • 9.2.2. Chart-PCR Clinical Singleplex Testing Growth
  • 9.3. PCR Research
    • 9.3.1. Table PCR Research-by Country
    • 9.3.2. Chart-PCR Research Growth
  • 9.4. PCR Other Application
    • 9.4.1. Table PCR Other Application-by Country
    • 9.4.2. Chart-Other Application Growth

10. Global PCR Markets-By Technology

  • 10.1. qPCR
    • 10.1.1. Table qPCR-by Country
    • 10.1.2. Chart-qPCR Growth
  • 10.2. dPCR
    • 10.2.1. Table dPCR-by Country
    • 10.2.2. Chart-dPCR Growth
  • 10.3. Other Technology
    • 10.3.1. Table Other Technology-by Country
    • 10.3.2. Chart-Other Technology Growth

11. Global PCR Markets-By Product

  • 11.1. PCR Instruments
    • 11.1.1. Table PCR Instruments-by Country
    • 11.1.2. Chart-PCR Instruments Growth
  • 11.2. PCR Nucleic Acid Extraction
    • 11.2.1. Table PCR Nucleic Acid Extraction-by Country
    • 11.2.2. Chart-PCR Nucleic Acid Extraction Growth
  • 11.3. PCR Consumables
    • 11.3.1. Table PCR Consumables-by Country
    • 11.3.2. Chart-PCR Consumables Growth
  • 11.4. PCR Services
    • 11.4.1. Table Services-by Country
    • 11.4.2. Chart-PCR Services Growth

12. Global PCR Markets-By Place

  • 12.1. PCR Clinical Laboratory
    • 12.1.1. Table PCR Clinical Clinical Laboratory-by Country
    • 12.1.2. Chart-PCR Clinical Clinical Laboratory Growth
  • 12.2. PCR Point of Care
    • 12.2.1. Table PCR Point of Care-by Country
    • 12.2.2. Chart-PCR Point of Care Growth
  • 12.3. PCR Commercial
    • 12.3.1. Table PCR Commercial-by Country
    • 12.3.2. Chart-PCR Commercial Growth
  • 12.4. PCR Pharmaceutical
    • 12.4.1. Table PCR Pharmaceutical-by Country
    • 12.4.2. Chart-PCR Pharmaceutical Growth
  • 12.5. PCR Other Place
    • 12.5.1. Table PCR Other Place-by Country
    • 12.5.2. Chart-PCR Other Place Growth

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule